coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Turton PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U79678 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,238

    Registered population

    58.2% aged 18–64

    21.9%

    Aged 65+

    ICB 14.9% · England 17.9%

    11.8%

    Ethnic minority (non-White)

    6.6% Asian · England 9.6%

    19.5%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~8,940

    Core20 residents (est.)

    Resident basis; registered basis ~9,389 · see page 3

    7,541

    Hypertension register

    +8.35% in 3 yrs · England +5.60%

    336

    SMI register

    9.3% of Bolton (LAD)'s

    1,002

    COPD register

    Reviews -3.99% in 3 yrs

    Forecast to 2030

    9,053

    Hypertension patients, 2030

    +1,512 on today

    58.8%

    QRISK ≥20% on statins, 2030

    +1.22pp over 3 yrs

    5.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.3%
    Lipid therapy lags across high-risk cohorts.

    QRISK ≥ 20% lipid therapy is 56.3% (England 63.6%) and CKD is 64.0% (England 70.3%), which may reflect recall gaps requiring local audit.

    -1.5%
    Annual review rates fell from 2023 to 2025.

    Three-year changes were -1.5% for heart failure (England +8.7%), -2.4% for asthma (England +4.4%) and -4.0% for COPD (England +2.8%).

    71.7%
    Hypertension blood pressure control exceeds comparators.

    Blood pressure control reaches 71.7% (Bolton 69.7%, ICB 71.4%, England 70.3%), alongside 77.5% breast screening coverage (England 69.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 21.9% aged 65+, Turton PCN has an older, predominantly White population

    Turton PCN serves 45,238 registered patients, with an older profile: 21.9% (9,925 patients) are aged 65+, exceeding Bolton (14.7%), NHS Greater Manchester ICB (14.9%) and England (17.9%). Projected list growth to 2030 is 1.3% (Bolton 1.3%, ICB 1.6%, England 2.3%, unverified methodology). In associated resident areas (Census basis, not registered patients), 88.2% are White, above Bolton (72.0%), the ICB (76.4%) and England (81.1%), while Asian / Asian British residents comprise 6.6% (Bolton 20.1%, ICB 13.6%, England 9.6%).

    Age profile

    0–1719.8%
    18–6458.2%
    65+21.9%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White88.2%
    Asian6.6%
    Mixed2.3%
    Black2.1%
    Other0.8%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 19.5% overall but practice shares span 47.1 percentage points

    Turton PCN's Core20 share is 19.5%, below Bolton (47.8%), NHS Greater Manchester ICB (40.7%) and England (21.0%), with an average IMD decile of 6.2. Across practices, shares span a 47.1 pp range. Crompton View Surgery records 47.1% (2,867 estimated patients) and Harwood Medical Centre records 31.1% (3,779 estimated patients), whereas Edgworth Medical Centre and Bromley Meadows Surgery record 0.0%. The PCN rate and practice-weighted share (20.8%) differ by 1.27 percentage points. Delivery may need to balance patient concentration against volume across these practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Crompton View47.1% · 2,867 patients
    Oaks33.1% · 2,269 patients
    Harwood31.1% · 3,779 patients
    Mandalay5.7% · 474 patients
    Edgworth0.0% · 0 patients
    Bromley Meadows0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    336

    SMI register

    0.75% recorded prevalence

    211

    Learning disability register

    0.47% recorded prevalence

    7

    Care homes, 252 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    Turton PCN records 211 learning disability patients (0.5% vs England 0.6%) and 336 severe mental illness patients (0.8% vs England 1.0%), alongside 7 care homes with 252 beds in its catchment. For Bolton, the autumn 2025 snapshot recorded 5 people sleeping rough, while the borough unpaid carer rate was 9.8% (unpaid carers were not captured at PCN level).

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 87.1% (England 83.4%), while BMI checks rose +0.3 pp over 2023 to 2025 (England +5.1 pp). Psychosis alcohol recording is 80.3% (England 81.8%). Annual physical health recording lags national gains despite strong blood pressure monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,541

    Hypertension register

    +8.35%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    +1.59pp

    BP control, under 80

    ≤140/90 · +0.83pp aged 80+

    +1,512

    More patients by 2030

    Forecast 9,053 (19.63%)

    Hypertension case-finding and control

    Turton PCN records a hypertension prevalence of 16.7% (7,541 patients), above Bolton (14.8%), NHS Greater Manchester ICB (14.4%) and England (15.2%). Blood pressure monitoring reached 91.7% (England 90.0%), and 71.7% are treated to target (England 70.3%). Among patients under 80, control is 68.3% (England 67.8%), and for those aged 80 and over it is 83.3% (England 81.2%). However, recent reading growth over 2023 to 2025 (+1.9%) trailed England (+3.6%). Crude rates exclude unrecorded need, and denominators include personalised care adjustments. Higher blood pressure control than national benchmarks provides a solid foundation, but slower recent review growth means clinicians should ensure annual blood pressure monitoring keeps pace across all practices.

    Lipids and statins

    Turton PCN trails England on lipid therapy: QRISK ≥ 20% reaches 56.3% (England 63.6%), CKD 64.0% (England 70.3%), diabetes without CVD 67.3% (England 73.2%), and diabetes with CVD 80.0% (England 84.4%). Fewer at-risk patients receive lipid-lowering therapy than national rates imply, making a systematic statin recall audit the primary clinical priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202665,480£2.20£1.94£1.86£144,056
    Cardiovascular (all), 2025105,693£4.85£3.15£3.33£512,611

    In 2026, the PCN prescribed 65,480 lipid-modifying items at £2.20 per item, above Bolton (£1.81), NHS Greater Manchester ICB (£1.94) and England (£1.86). Spending was £22,263 more than at England's unit cost. Higher unit costs alongside lower treatment coverage indicate an opportunity to review formulary choices and align prescribing with lower-cost regimens.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.44%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.79%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.6% (3,235 patients) and COPD prevalence is 2.2% (1,002 patients). Although annual reviews exceed England—asthma at 68.4% (England 65.7%) and COPD at 77.9% (England 76.4%)—both fell over 2023 to 2025: asthma fell 2.4% (England +4.4%) and COPD fell 4.0% (England +2.8%). An estimated 1,023 asthma patients remain unreviewed, while youth asthma prescribing is 1,949 items per 1,000 population aged 5 to 19 (England 1,488). Falling review rates alongside higher youth prescribing could reflect delivery strain, which capacity audits could test.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.3% (1,959 patients), above England (3.8%). In childhood immunisation, age-5 MMR dose 1 is 97.7% (England 91.7%), exceeding the 95.0% target by 2.7 pp. However, dose 2 is 90.6% (below target by 4.4 pp), reflecting a 7.1 pp drop between doses. The 4-in-1 booster coverage is 89.1% (below target by 5.9 pp). Timely completion before school entry requires focused recall to close the second-dose protection gap.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.1%

    England 91.0%

    6-in-1 complete primary course at 24 months96.9%

    England 92.2%

    MMR dose 1 at 24 months92.8%

    England 88.3%

    MMR dose 2 at age 590.6%

    England 82.8%

    4-in-1 pre-school booster at age 589.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage in NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679 staged cancers), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition. Known stage was recorded for 70.8% of 16,492 registered cancers (England 67.0%). Reaching 75.0% requires about 2,270 extra early-stage cases ICB-wide. Locally, breast screening is 77.5% (England 69.9%) and cervical screening is 73.2% (England 66.8%), though cervical screening coverage fell 2.3% (England -1.0%) over 2023 to 2025. System stage data describes the ICB rather than PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Bolton NHS Foundation Trust achieved 80.5% on the 28-day faster diagnosis standard (standard 75.0%), ahead of NHS Greater Manchester Integrated Care Board (79.5%) and England (79.3%). However, 62-day referral to treatment was 69.7%, trailing East Lancashire Hospitals NHS Trust (73.2%), Northern Care Alliance NHS Foundation Trust (78.6%), the ICB (75.7%) and England (71.2%), falling 15.3 pp below the 85.0% standard. Bolton NHS Foundation Trust met the 31-day standard at 96.5% (standard 96.0%). Six-week diagnostic waits reached 25.3% for cystoscopy and 2.0% for MRI (England 21.4%). Provider waiting times describe trust performance rather than PCN delivery.

    Pathways within standard (%)BoltonNorthern Care AllianceEast LancashireGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2081.5079.5379.32
    31-day treatment (96%)96.5094.5498.1196.4992.50
    62-day referral to treatment (85%)69.6678.6573.1675.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceEast LancashireEngland
    MRI2.055.090.4321.40
    CT19.404.100.159.92
    Echocardiography3.4831.480.0028.48
    Colonoscopy1.3340.040.9530.83
    Gastroscopy2.0636.481.1629.02
    All 15 DM01 tests15.7815.713.2523.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 51.6% of all community service contacts among borough residents (25,460 of 49,315 contacts). Community provider activity was not captured at PCN level, representing wider borough resident activity rather than Turton PCN patients directly.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Patient experience spans 28.0 pp across practices despite clinical achievement reaching 100.0%

    In 2025/26, overall QOF achievement ranged from 87.1% at Edgworth Medical Centre to 97.5% at Crompton View Surgery, against 92.5% in England. Vaccination and immunisation achievement showed a 42.7 pp spread, from 35.3% at The Oaks Family Practice to 78.0% at Crompton View Surgery (England 55.2%). Clinical domain scores reached 100.0% at Mandalay Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Crompton View9547.183.1%76.4%98.1%
    Edgworth1210.087.1%84.9%95.5%
    Bromley Meadows1130.073.1%75.5%92.1%
    Mandalay1095.756.8%74.5%79.2%
    Harwood12631.152.5%87.3%72.2%
    Oaks9733.159.5%71.2%70.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)7 (252 beds)n/aSchools (catchment)51n/a
    Children's centres418Places of worship29144
    Libraries27Primary schools (LA maintained)1361
    Primary academies1032Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Statin recall and formulary review

    Lipid therapy trails England across four QOF cohorts: QRISK ≥ 20% at 56.3% (England 63.6%), CKD 64.0% (70.3%), diabetes without CVD 67.3% (73.2%) and with CVD 80.0% (84.4%). Unit cost is £2.20 (£22,263 more than England's unit cost across 65,480 items). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Chronic disease annual review recall

    Over 2023 to 2025, reviews fell while England's rose: asthma fell 2.4% (England +4.4%; current 68.4%, 1,023 of 3,235 register patients unreviewed), COPD fell 4.0% (England +2.8%; current 77.9%) and heart failure fell 1.5% (England +8.7%; current 83.3%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.5% (211 of 45,238 patients), below Bolton (0.6%) and England (0.6%), giving an unadjusted benchmark gap of +55 (England) to +63 (Bolton) patients despite +20.1% growth over 2023 to 2025. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older population proactive care review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 preventive outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check protocol (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Annual blood pressure review audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Statin recall and formulary review (p12)Hypertension: QOF prevalence · Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Chronic disease annual review recall (p12)Asthma register · COPD register · Heart failure registerCore20PLUS5 respiratoryPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15